SR-17018 is a drug which acts as a biased agonist at the μ-opioid receptor, selective for activation of the G-protein signalling pathway over β-arrestin 2 recruitment.

[1] In animal studies it produces analgesic effects but with less respiratory depression and development of tolerance than conventional opioids.

[2][3][4][5] This pharmacology-related article is a stub.

You can help Wikipedia by expanding it.